This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile MedicationOrder.
AC followed by Paclitaxel + Trastuzumab Course 1
Name: Cyclophosphamide in AC (Doxorubicin + Cyclophosphamide)
Course: 1
Agent Protocols Options:
Cyclophosphamide 600 mg/m^2 IV over 30 minutes D1
Offset: None
Cycle length: Q21D x 4 cycles
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.